E-LIB Suche - Ergebnisse für: Turkish Oncology Group

1

Involved-site Radiotherapy Delineation Dilemmas in the Trea..:

Yilmaz, M.T. ; Kamer, S. ; Agaoglu, F...
Clinical Oncology. 36 (2024) 2 - p. 80-86 , 2024

Link: https://doi.org/10.1016/..

2

Risk factors of radiation pneumonitis in patients with NSCL..:

Ergen, Sefika A. ; Dincbas, Fazilet O. ; Yücel, Birsen...
The Clinical Respiratory Journal. , 2020

Link: https://doi.org/10.1111/..

3

Pertuzumab, trastuzumab and taxane-based treatment for visc..:

Turkish Oncology Group ; Esin, Ece ; Oksuzoglu, B....
Cancer Chemotherapy and Pharmacology. 83 (2018) 1 - p. 131-143 , 2018

Link: https://doi.org/10.1007/..

4

A randomized Phase III trial of etoposide, epirubicin, and ..:

Turkish Oncology Group ; ?�li, Fikri ; �elik, ?smail...
Cancer. 83 (1998) 12 - p. 2475-2480 , 1998

Link: https://doi.org/10.1002/..

5

68P Real-world clinical and treatment-related outcomes in s..:

Yildirim, E. Caliskan ; Semiz, H.S. ; Akyildiz, A....
ESMO Open. 9 (2024) - p. 102297 , 2024

Link: https://doi.org/10.1016/..

6

Survival of Patients With Metastatic Rectum Cancer Who Unde..:

Almuradova, Elvina ; Yalcin, Suayib ; Arıkan, Rukiye...
Cureus. , 2023

Link: https://doi.org/10.7759/..

7

The percentage of ALK-positive cells and the efficacy of fi..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 4141-4148 , 2022

Link: https://doi.org/10.1007/..

8

The real-life efficacy and safety of osimertinib in pretrea..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology. 148 (2021) 6 - p. 1501-1508 , 2021

Link: https://doi.org/10.1007/..

9

Determining the Patterns of Care to Adolescent and Young Ad..:

Sert, F. ; Kamer, S. ; Yukselen Guney, Y.
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e429 , 2020

Link: https://doi.org/10.1016/..

10

Comments on "Prognostic factors for survival in patients wi..:

Yilmaz, Melek Tugce ; Elmali, Aysenur ; Yazici, Gozde
Journal of Oncology Pharmacy Practice. 25 (2019) 8 - p. 2060-2062 , 2019

Link: https://doi.org/10.1177/..

11

Prognostic factors for survival in patients with mucosal an..:

Arzu Yaşar, H ; Turna, Hande ; Esin, Ece...
Journal of Oncology Pharmacy Practice. 26 (2019) 2 - p. 267-272 , 2019

Link: https://doi.org/10.1177/..

12

Prognostic factors for survival in patients with metastatic..:

Urun, Yuksel ; Yasar, H Arzu ; Turna, Hande...
Journal of Oncology Pharmacy Practice. 25 (2018) 7 - p. 1658-1664 , 2018

Link: https://doi.org/10.1177/..

13

Changes in lifestyle upon diagnosis of cancer or other chro..:

Turhal, Nazim Serdar ; Akinci, Figen ; Haciabdullahoglu, Yasemin...
Journal of Health Psychology. 23 (2016) 4 - p. 561-566 , 2016

Link: https://doi.org/10.1177/..

14

Benefit of Bevacizumab-Based Frontline Therapy in Patients ..:

Artaç, Mehmet ; Coşkun, Hasan Şenol ; Dane, Faysal...
Journal of Gastrointestinal Cancer. 47 (2016) 3 - p. 264-272 , 2016

Link: https://doi.org/10.1007/..

15

Do High-risk Features Support the Use of Adjuvant Chemother..:

Artac, Mehmet ; Turhal, Nazim Serdar ; Kocer, Murat...
Tumori Journal. 100 (2014) 2 - p. 143-148 , 2014

Link: https://doi.org/10.1177/..